Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04129151
Title Palbociclib + Ganitumab In Ewing Sarcoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Dana-Farber Cancer Institute
Indications

Ewing sarcoma

neuroectodermal tumor

Therapies

Ganitumab + Palbociclib

Age Groups: child | adult
Covered Countries USA

Additional content available in CKB BOOST